Wow! $22 price target!

June 27, 2011
Jefferies is maintaining its Buy rating and $22 price target on shares of Amylin Pharmaceuticals (NASDAQ: AMLN) following a positive weekend update at ADA.

 

Fantastic! A boost to $13.06 already. If analyst firms are correct, we should see $22 in a couple of weeks. I am holding out until $40-60 after approval in the US. Keep the rally a..l..i..v..e!

 

Best Relative Performance in the Biotechnology Industry Detected in Shares of Amylin Pharmaceuticals (AMLN, NABI, SGMO, PCYC, DUSA) Published on Tue, 06/28/2011 - 05:04
By Robert Cotter in Fast Lane, amln, DUSA, NABI, PCYC, SGMO, amylin pharmaceuticals....

 

Icahn's Goal For Amylin... ****29-Jun-11 09:31 am****
Icahn may just be working towards having Amylin achieve U.S. approval in the United States for Bydureon by the 1Q 2012, at which time he will put Amylin on the auction block to start the bidding process for the company. I expect U.S. approval will get Amylin's stock price near $30 + and a buyout premium will be added to that number. Now if Amylin and Takeda issue really positive news (Phase III Trials) about Pramlintide + Leptin later this year, we could the stock trading well above $30 after Bydureon is approved. I honestly don't believe Amylin will be around in 2013 or I should say they will not be around as a totally independent company. If they are bought or merge with another company, the acquirer would be smart to keep Amylin whole as a subsidiary for R&D.
JMO
Kevinmik

 

from your lips to God's ears....

 

Another 3% jump today. At this rate, $22 will be reached in no time. I will have 100 people over for BBQ and swim party this long weekend.

 

Up 1.4% today. Grande party this weekend. We expect a big bounce to $20 next week. People keep the good time rolling!

 

I have faith in our mgt. When they say that they will grow GLP1 market....I was one of the few loyalist who place complete trust in them. Today, I see a pot at the end of the rainbow. My boss and his boss deserve a nice gift tomorrow. Off to UTC I go.

 

Congrats! 10 biggest percentage gainers on Nasdaq at 1 p.m.:
Amylin Pharmaceuticals Inc. rose 5.6 percent to $14.48.

 

And in typical Amylin pattern, it will drop again next week.

 

See?? I told you it would drop. At least they are consistent!

 

Back to $13.10. When will you realize that your living a pipe dream right now. AMLN will never hit $20, much less $22. The stock is crap; the company is crap. Face reality.

 

Opened at $12.92 today!! Awesome! That $22 share price is right around the corner (unfortunately, that corner is WAAAAAAAAAYYYYYYYYY away).

 

Closed at $12.82 today. Lowest stock price since Bydureon didn't get approved. Amylin sure is awesome--looks like the investors love it.

 

AMLN trading at around $10 a share now. Where's your huge jump in price??? You guys suck.

 

Please remind me why Dan B. is still running that ship??

 

Trading at $9.95 today. Dismal.

 

Closed on Friday at $10.11. A far cry from $22.

 

Trading at $11.18 today. Congrats--you made it back to half of your $22 target price!

 

Steady as the captain and his fine crew steer towards icebergs.